Concourse Financial Group Securities’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6762 |
|
|
2024
Q4 | – | Sell |
-1,000
| Closed | -$7.22K | – | 7342 |
|
|
2024
Q3 | $7.22K | Hold |
1,000
| – | – | ﹤0.01% | 1771 |
|
|
2024
Q2 | $10.9K | Hold |
1,000
| – | – | ﹤0.01% | 1668 |
|
|
2024
Q1 | $18.7K | Sell |
1,000
-1
| -0.1% | -$19 | ﹤0.01% | 1524 |
|
|
2023
Q4 | $21.7K | Hold |
1,001
| – | – | ﹤0.01% | 1464 |
|
|
2023
Q3 | $20.6K | Buy |
+1,001
| New | +$20.6K | ﹤0.01% | 1426 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6942 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6693 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6707 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6530 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6468 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6346 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6290 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6099 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5890 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5692 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5531 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5317 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5177 |
|
|
2020
Q1 | – | Sell |
-93
| Closed | -$7K | – | 5137 |
|
|
2019
Q4 | $7K | Buy |
93
+18
| +24% | +$1.36K | ﹤0.01% | 1547 |
|
|
2019
Q3 | $11K | Sell |
75
-20
| -21% | -$2.93K | ﹤0.01% | 1129 |
|
|
2019
Q2 | $17K | Sell |
95
-8
| -8% | -$1.43K | ﹤0.01% | 1310 |
|
|
2019
Q1 | $16K | Buy |
103
+1
| +1% | +$155 | ﹤0.01% | 1350 |
|
|
2018
Q4 | $9K | Hold |
102
| – | – | ﹤0.01% | 1465 |
|
|
2018
Q3 | $14K | Buy |
+102
| New | +$14K | ﹤0.01% | 989 |
|